EPISODE · May 28, 2024 · 7 MIN
Tuesday, May 28, 2024
from The Gist Healthcare Podcast
Novo Nordisk reports that its GLP-1 drug Ozempic could help treat kidney disease. An advisory panel recommends the FDA approve Guardant Health’s colon cancer blood test. And Louisiana lawmakers vote to reclassify abortion pills as controlled dangerous substances. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
Tuesday, May 28, 2024
0:00
7:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Gist Healthcare Podcast?
This episode is 7 minutes long.
When was this The Gist Healthcare Podcast episode published?
This episode was published on May 28, 2024.
Can I download this The Gist Healthcare Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!